- Institutional flow: Scheer Rowlett & Associates added shares; Pier Capital trimmed; GAM Holding initiated a stake. 1
- Earnings pulse (Q2 FY26, reported Nov. 6): Revenue C$272.6M (+1.8% Y/Y); adjusted loss C$0.14/share; DTC +21.8%; SG&A increased ahead of peak season. 2
- Capital returns:New NCIB (buyback) allows repurchase of up to 4,578,677 subordinate voting shares from Nov. 10, 2025 to Nov. 9, 2026. 3
- Street chatter (latest):Barclays lowers PT to $11 (Equal‑Weight); UBS nudges PT to $12 (Neutral). 4
- Stock check: GOOS recently traded around $13.00 (NYSE). (See live chart above.)
What changed today (Nov. 11, 2025)
The most recent developments as of Tuesday, Nov. 11 revolve around post‑earnings positioning and new sell‑side targets. Barclays cut its 12‑month price target to $11 while maintaining Equal‑Weight, citing a more cautious view after last week’s results. UBS raised its target to $12 but stayed Neutral, reflecting improving momentum but limited near‑term conviction. 4
Meanwhile, the company’s renewed normal course issuer bid (NCIB) formally began on Nov. 10, enabling buybacks of up to 4.58M shares over the next 12 months—about 10% of the public float—potentially providing a modest support to per‑share metrics during volatility. 3
The latest 13F moves around Canada Goose
Recent regulatory filings tracked by MarketBeat show a mixed, but active, institutional tape in Q2:
- Scheer Rowlett & Associatesincreased its position by 2.7% to 1,047,971 shares (≈1.08% of the company). 1
- Pier Capital LLCreduced exposure by 57,893 shares (‑7.2%) to 742,152 shares. 5
- GAM Holding AGinitiated a 100,000‑share position (≈0.10% ownership). 6
MarketBeat also notes that institutional holders control ~83.6% of outstanding shares—a level that tends to amplify sensitivity to fund flows, analyst revisions, and macro signals. 5
Earnings pulse: DTC strength vs. margin pressure
On Nov. 6, Canada Goose reported Q2 FY26 results: revenue grew 1.8% to C$272.6M, driven by Direct‑to‑Consumer up 21.8%, while wholesale slipped ~1%. The company posted an adjusted loss of C$0.14/share, wider than consensus, as SG&A rose ahead of the holiday peak due to store labor/training and heavier marketing. Shares initially traded lower on the miss. 2
The company highlighted inventory down ~3% Y/Y and reiterated a focus on expanding beyond core parkas while sharpening in‑season newness and marketing. 3
Capital returns: A new 12‑month buyback window
In tandem with Q2 results, Canada Goose renewed its NCIB, authorizing repurchases of up to 4,578,677 subordinate voting shares from Nov. 10, 2025 through Nov. 9, 2026 (early termination of the prior NCIB on Nov. 9). Management framed the move as an “appropriate and desirable” use of excess cash within its capital‑allocation plan. 3
Street view: Targets reset into peak season
- Barclays:PT to $11, Equal‑Weight (Nov. 10). 4
- UBS:PT to $12 from $11, Neutral (Nov. 7). 7
- (Context) Post‑print coverage noted mixed takeaways: strong DTC, softer wholesale, and higher opex pressuring near‑term margins. Reuters also flagged the wider‑than‑expected loss and demand softness. 2
Operations & brand notes to watch into holiday
- Retail footprint: The company counted 77 permanent stores exiting Q2 and relocated its Paris store to the Champs‑Élysées, part of efforts to elevate brand presentation in key global cities. 3
- Holiday setup: Marketing and labor investments front‑loaded into Q2 should translate into fuller store readiness and campaigns during peak demand—management’s intended trade‑off for near‑term SG&A pressure. 3
Why it matters
For investors, the combination of active institutional rebalancing, a fresh buyback, and diverging analyst targets sets the stage for volatility as Canada Goose heads into its most consequential quarter. Execution on DTC, control of operating costs, and any updates on wholesale trends will likely influence how quickly sentiment can rebound from last week’s earnings miss. 2
Sources
- Institutional activity: MarketBeat coverage of Scheer Rowlett (Nov. 10), Pier Capital (Nov. 2), and GAM Holding (Nov. 2). 1
- Earnings & NCIB details: Company IR press release (Nov. 6). 3
- Earnings coverage: Reuters recap (Nov. 6). 2
- Analyst moves: Barclays via GuruFocus (Nov. 10); UBS via The Fly/TipRanks (Nov. 7). 4
Disclosure: This article aggregates publicly available filings and reports. It is for informational purposes only and is not investment advice.
